SavedAdd your journal

Journals / Yeni Tıp Dergisi / 2013 / Cilt: 30 - Sayı: 2

Kanser hastalarında ortalama platelet volümü platelet sayısı, risk faktörleri ile tromboembolik olaylar arasındaki ilişki

The relationship among mean platelet volume, platelet count, risk factors and thromboembolic event in patients with cancer

Hasan MUTLU
Zeki AKÇA
Yasemin CİHAN BENDERLİ
Abdülsamet ERDEN
Tuncay ASLAN
Hediye UĞUR
Abdullah BÜYÜKÇELİK
Pages
89–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: During chemotherapy period, prophylaxis for thromboembolic event should be offered to the patients who were newly diagnosed with cancer for one year especially to whom with smoking.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: For platelet volume, mean platelet volume is an indicator.
📊
Key Findings & Data:Material and Method: Consecutive 168 patients suffering from cancer have been followed-up for one year.
💡
Conclusion & Impact:Conclusion: During chemotherapy period, prophylaxis for thromboembolic event should be offered to the patients who were newly diagnosed with cancer for one year especially to whom with smoking.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: For platelet volume, mean platelet volume is an indicator. We aimed to investigate the relationship among mean platelet volume, platelet count with thromboembolic event and detected risk factors for thromboemboli in patients who were newly diagnosed during one year follow-up. Material and Method: Consecutive 168 patients suffering from cancer have been followed-up for one year. Mean platelet volume an d platelet count, age, sex, cancer type, stage, comorbidity, smoking, chemotherapy intake and thromboembolic events were analysed. Results: While in the post treatment mean platelet volume a significant decrease was seen, post treatment platelet were counted as similar values according to first values at the time of diagnosis in patients of thromboembolic events (+). Chemotherapy intake and smoking were the risk factors for thromboemboli; smoking was the only independent one among these factors. Conclusion: During chemotherapy period, prophylaxis for thromboembolic event should be offered to the patients who were newly diagnosed with cancer for one year especially to whom with smoking.

🔖

Cite This Article

MUTLU, H., AKÇA, Z., BENDERLİ, Y. C., ERDEN, A., ASLAN, T., UĞUR, H., BÜYÜKÇELİK, A. (2013). Kanser hastalarında ortalama platelet volümü platelet sayısı, risk faktörleri ile tromboembolik olaylar arasındaki ilişki. Yeni Tıp Dergisi, Cilt: 30 - Sayı: 2, 89–92. https://ajindex.com/articles/338202

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166(4):458-64
  2. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol 2003;21(22):4194-9
  3. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004;103(6):2096-104
  4. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357(24):2482-94
  5. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340(2):115-26
  6. Alper AT, Akyol A, Hasdemir H, Yildirim A, Nurkalem Z, Güvenç TS, et al. Effect of cardiac resynchronization therapy on mean platelet volume. Acta Cardiol 2008;63(6):735-9
  7. Yavuz B, Ertugrul DT, Yalcin AA, Kucukazman M, Ata N, Dal K. Increased mean platelet volume in rheumatic mitral stenosis: a possible factor for thromboembolic events. J Cardiol 2009;53(2):204-7
  8. Gulcan M, Varol E, Etli M, Aksoy F, Kayan M. Mean platelet volume is increased in patients with deep vein thrombosis. Clin Appl Thromb Hemost 2012;18(4):427-30
  9. Varol E, Uysal BA, Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension. Clin Appl Thromb Hemost 2011;17(6): E171-4
  10. Kosus N, Kosus A, Yildirim M, Duran M, Turhan NO. Mean platelet volume as a marker of thrombosis in patients with missed abortion. Acta Haematol 2011;125 (4): 208-9
  11. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35(7):1688-91
  12. Smith NM, Pathansali R, Bath PM. Platelets and stroke. Vasc Med 1999;4(3):165–72
  13. Mutlu H, Berk V, Karaca H, Erden A, Aslan T, Akca Z. Treatment Regimen With Bevacizumab Decreases Mean Platelet Volume in Patients With Metastatic Colon Cancer. Clin Appl Thromb Hemost 2012;18(5):546-8
  14. Maraveyas A, Johnson M. Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Br J Cancer 2009;100(12):1837-41
  15. Lee AYY, Khorana AA, Vascular Events. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer Principles & Practice Oncology. 8th ed. 2008; 2635
  16. Levitan N, Dowlati A, Remick SC, Ta